Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma.

Watchmaker, Payal B; Colton, Maggie; Pineo-Cavanaugh, Psalm L; Okada, Hideho

Watchmaker, Payal B; Colton, Maggie; Pineo-Cavanaugh, Psalm L; Okada, Hideho.

Affiliation

Watchmaker PB; Department of Neurosurgery, University of California, San Francisco.
Colton M; Department of Neurosurgery, University of California, San Francisco.
Pineo-Cavanaugh PL; Department of Neurosurgery, University of California, San Francisco.
Okada H; Department of Neurosurgery, University of California, San Francisco.

Curr Opin Oncol ; 34(6): 661-669, 2022 11 01.

Article in En | MEDLINE | ID: mdl-35855503

Subject(s)

Glioma; Receptors, Chimeric Antigen; Cytokines; Glioma/therapy; Humans; Immunotherapy, Adoptive/methods; T-Lymphocytes

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Chimeric Antigen / Glioma Limits: Humans Language: En Journal: Curr Opin Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google